Abbott Laboratories logo

Abbott Laboratories

ABT | NYSE
Chart Builder DCF Calculator
$102.92
+$0.31 (+0.30%)
Sep 21, 2026, 2:49 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
8.52B 7.62B 6.9B 9.88B 9.8B 6.84B
Short-Term Investments
417M 351M 383M 288M 450M 310M
Long-Term Investments
918M 886M 799M 766M 903M 1.03B
Other Long-Term Assets
17.3B 15.38B 5.98B 4.92B 3.97B 2.42B
Receivables
7.93B 6.93B 6.57B 6.22B 6.49B 6.41B
Inventory
6.49B 6.19B 6.57B 6.17B 5.16B 5.01B
Other Current Assets
2.64B 2.57B 2.26B 2.66B 2.35B 1.87B
Total Current Assets
26B 23.66B 22.67B 25.22B 24.24B 20.44B
Property-Plant & Equipment
12.94B 11.73B 11.28B 10.28B 10.11B 10.13B
Goodwill & Intangibles
29.56B 29.76B 32.49B 33.25B 35.97B 38.53B
Total Long-Term Assets
60.72B 57.76B 50.54B 49.21B 50.96B 52.11B
Total Assets
86.71B 81.41B 73.21B 74.44B 75.2B 72.55B
Account Payables
4.24B 4.2B 4.3B 4.61B 4.41B 3.95B
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
3.31B 1.75B 1.33B 2.48B 999M 461M
Other Current Liabilities
5.54B 5.91B 6.13B 6.5B 5.77B 5.72B
Total Current Liabilities
16.5B 14.16B 13.84B 15.49B 13.11B 11.91B
Long-Term Debt
10.83B 12.63B 13.6B 14.52B 17.3B 18.53B
Other Long-Term Liabilities
3.73B 4.46B 4.78B 4.74B 5.74B 6.06B
Total Long-Term Liabilities
17.45B 19.36B 20.55B 22.04B 26.07B 27.64B
Total Liabilities
33.94B 33.51B 34.39B 37.53B 39.17B 39.55B
Total Debt
15.07B 15.28B 15.87B 17.95B 19.25B 19.89B
Book Value
52.77B 47.9B 38.83B 36.91B 36.02B 33B
Book Value Per Share
30.21 27.40 22.20 20.92 20.14 18.48
Common Stock
25.53B 25.15B 24.87B 24.71B 24.47B 24.15B
Retained Earnings
49.78B 47.26B 37.55B 35.26B 31.53B 27.63B
Comprehensive Income
-6B -7.91B -7.84B -8.05B -8.37B -8.95B
Shareholders Equity
52.13B 47.66B 38.6B 36.69B 35.8B 32.78B
Total Investments
1.34B 1.24B 1.18B 1.05B 1.35B 1.34B

© 2026 bestshares.com. All rights reserved.